Unknown

Dataset Information

0

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.


ABSTRACT: We evaluated the diagnostic accuracy of aspartate aminotransferase (AST)-to-platelet ratio index (APRI), fibrosis-4 index (FIB-4), AST/alanine aminotransferase (ALT) ratio (AAR), and age-platelet index (API) for significant fibrosis (Metavir F2-4) in low-replicative (HBV DNA <20,000 IU/mL) chronic hepatitis B virus (HBV) patients.The sensitivity, specificity, and area under the receiver-operating characteristic curve (AUROC) of HBeAg-negative, low-replicative (n = 213) and high-replicative (HBV DNA ?20,000 IU/mL, n = 153) patients was assessed.Overall, 113 patients (30.9%) had F2-4 fibrosis. Of the low and high-replicative patients, 40 (18.8%) and 73 (47.7%) had F2-4, respectively (P < 0.0001). APRI ?0.5 less frequently identified F2-4 fibrosis in low vs. high-replicative patients (48.7% vs. 69.6%, P = 0.032) and AAR identified it more frequently in low-replicative patients (37.5% vs. 19.4%, P = 0.037). FIB-4 and API were not different (P > 0.05) for identifying F2-4 fibrosis in low and high-replicative patients. Higher specificities were seen at the lowest cut-offs in low vs. high-replicative states for APRI (?0.5, 98% vs. 68.9%), AAR (84.3% vs. 76.6%), FIB-4 (?1.45, 97.5% vs. 87.8%) and API (>4, 94.8% vs. 93.8%). At ROC-defined thresholds, APRI (?0.33), AAR (?0.93), FIB-4 (?0.70) and API (>2) showed greater AUROCs for F2-4 diagnosis in low replicative (0.80, 0.62, 0.81 and 0.71, respectively) vs. high-replicative patients (0.73, 0.52, 0.67 and 0.69, respectively).All 4 biomarkers in both, low and high-replicative HBV demonstrate modest accuracy for fibrosis diagnosis at conventional cut-offs. Lowering the cut-offs may increase the diagnostic relevance of these biomarkers, particularly for APRI and FIB-4 in low-replicative disease.

SUBMITTER: Sanai FM 

PROVIDER: S-EPMC5574089 | biostudies-other | 2017 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications


<h4>Background</h4>We evaluated the diagnostic accuracy of aspartate aminotransferase (AST)-to-platelet ratio index (APRI), fibrosis-4 index (FIB-4), AST/alanine aminotransferase (ALT) ratio (AAR), and age-platelet index (API) for significant fibrosis (Metavir F2-4) in low-replicative (HBV DNA <20,000 IU/mL) chronic hepatitis B virus (HBV) patients.<h4>Methods</h4>The sensitivity, specificity, and area under the receiver-operating characteristic curve (AUROC) of HBeAg-negative, low-replicative (  ...[more]

Similar Datasets

| S-EPMC7388477 | biostudies-literature
| S-EPMC6212603 | biostudies-other
| S-EPMC3247188 | biostudies-literature
| S-EPMC2711538 | biostudies-literature
| S-EPMC3157356 | biostudies-literature
| S-EPMC8764302 | biostudies-literature
| S-EPMC5115865 | biostudies-literature
| S-EPMC7540526 | biostudies-literature
| S-EPMC5135658 | biostudies-literature
| S-EPMC4737301 | biostudies-literature